Bank of America
ACET icon

Bank of America’s Adicet Bio ACET Stock Holding History

Bank of America’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,288
Closed -$10.8K – 5696
2025
Q4 		$10.8K Hold
1,288
– – ﹤0.01% 6148
2025
Q3 		$16.7K Sell
1,288
-2
-0.2% -$24 ﹤0.01% 7109
2025
Q2 		$12.6K Buy
1,290
+6
+0.5% +$63 ﹤0.01% 7146
2025
Q1 		$15.5K Sell
1,284
-1,051
-45% -$15K ﹤0.01% 7027
2024
Q4 		$35.9K Sell
2,335
-2,055
-47% -$38.8K ﹤0.01% 6715
2024
Q3 		$101K Sell
4,390
-12
-0.3% -$269 ﹤0.01% 6320
2024
Q2 		$85.2K Sell
4,402
-1,973
-31% -$52.9K ﹤0.01% 6319
2024
Q1 		$240K Buy
6,375
+3,391
+114% +$140K ﹤0.01% 5795
2023
Q4 		$90.2K Buy
2,984
+144
+5% +$3.14K ﹤0.01% 6412
2023
Q3 		$62.2K Buy
2,840
+716
+34% +$25.3K ﹤0.01% 6430
2023
Q2 		$82.6K Sell
2,124
-267
-11% -$23.6K ﹤0.01% 6274
2023
Q1 		$220K Sell
2,391
-8,887
-79% -$1.12M ﹤0.01% 5873
2022
Q4 		$1.61M Buy
11,278
+3,729
+49% +$931K ﹤0.01% 4458
2022
Q3 		$1.72M Buy
7,549
+6,134
+433% +$1.56M ﹤0.01% 4418
2022
Q2 		$330K Sell
1,415
-806
-36% -$177K ﹤0.01% 5733
2022
Q1 		$710K Sell
2,221
-2,358
-51% -$542K ﹤0.01% 5541
2021
Q4 		$1.28M Buy
4,579
+3,786
+477% +$650K ﹤0.01% 5003
2021
Q3 		$99K Buy
793
+298
+60% +$37K ﹤0.01% 6729
2021
Q2 		$82K Sell
495
-443
-47% -$90.2K ﹤0.01% 6614
2021
Q1 		$196K Buy
938
+910
+3,250% +$209K ﹤0.01% 6053
2020
Q4 		$6K Sell
28
-118
-81% -$24.2K ﹤0.01% 6796
2020
Q3 		$28K Buy
146
+66
+83% +$16.7K ﹤0.01% 6208
2020
Q2 		$19K Buy
80
+13
+19% +$2.55K ﹤0.01% 6275
2020
Q1 		$7K Sell
67
-25
-27% -$3.71K ﹤0.01% 6438
2019
Q4 		$15K Sell
92
-497
-84% -$252K ﹤0.01% 6560
2019
Q3 		$584K Buy
589
+185
+46% +$207K ﹤0.01% 4966
2019
Q2 		$461K Sell
404
-3,140
-89% -$2.85M ﹤0.01% 5121
2019
Q1 		$2.71M Buy
3,544
+3,131
+758% +$2.84M ﹤0.01% 3741
2018
Q4 		$398K Buy
413
+25
+6% +$32.9K ﹤0.01% 5083
2018
Q3 		$658K Buy
388
+202
+109% +$263K ﹤0.01% 4770
2018
Q2 		$191K Buy
186
+15
+9% +$16.1K ﹤0.01% 5438
2018
Q1 		$184K Buy
+171
New +$314K ﹤0.01% 5413

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bank of America's ACET Position: Q1 2026 in Review

Bank of America sold out of Adicet Bio (ACET) in Q1 2026, closing a stake of 1,288 shares — an estimated $10.8K sold.

Bank of America first reported a position in ACET in Q1 2018 and held it in 32 quarters. The position peaked at $2.71M in Q1 2019. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Bank of America reported no remaining Adicet Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,288 Adicet Bio shares in Q1 2026, an estimated $10.8K.
  • Bank of America first reported a position in Adicet Bio in Q1 2018 and held it in 32 quarters.
  • Bank of America's Adicet Bio position peaked at $2.71M in Q1 2019.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.